MIM
BTMD icon

MetLife Investment Management’s Biote Corp BTMD Stock Holding History

MetLife Investment Management’s Portfolio BTMD Stock Details BTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-16,582
Closed -$102K – 2788
2024
Q4 		$102K Hold
16,582
– – ﹤0.01% 2613
2024
Q3 		$92.5K Buy
16,582
+9,343
+129% +$62.3K ﹤0.01% 2657
2024
Q2 		$54.1K Buy
+7,239
New +$44.7K ﹤0.01% 2748

Other funds holding BTMD

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
BP
Bandera Partners New York $221M AUM 10.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MetLife Investment Management's BTMD Position: Q1 2025 in Review

MetLife Investment Management sold out of Biote Corp (BTMD) in Q1 2025, closing a stake of 16,582 shares — an estimated $102K sold.

MetLife Investment Management first reported a position in BTMD in Q2 2024 and held it in 3 quarters. The position peaked at $102K in Q4 2024. 90 funds tracked by Wall St. Rank hold BTMD as of Q1 2025.

  • MetLife Investment Management reported no remaining Biote Corp position as of Q1 2025 after selling out during the quarter.
  • MetLife Investment Management sold 16,582 Biote Corp shares in Q1 2025, an estimated $102K.
  • MetLife Investment Management first reported a position in Biote Corp in Q2 2024 and held it in 3 quarters.
  • MetLife Investment Management's Biote Corp position peaked at $102K in Q4 2024.
  • 90 funds tracked by Wall St. Rank held Biote Corp as of Q1 2025.

Based on MetLife Investment Management's 13F filing for Q1 2025, filed 14 May 2025.